2018
DOI: 10.1016/j.diabres.2018.02.025
|View full text |Cite
|
Sign up to set email alerts
|

Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
104
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 125 publications
(112 citation statements)
references
References 33 publications
1
104
2
Order By: Relevance
“…In another study of 62 patients with amyotrophic lateral sclerosis, the Cr/CysC ratio was shown to be associated with the severity of muscle loss (Tetsuka, ). Recently, a study in 285 patients with type 2 diabetes also indicated that the Cr/CysC ratio was consistent with the skeletal muscle mass estimated by bioelectrical impedance and could be used as a practical screening marker for sarcopenia (Osaka et al, ). In our study, we did not use the above methods except the Cr/CysC ratio to evaluate the muscle mass, due to the clinical instability of the patients at NCU admission.…”
Section: Discussionmentioning
confidence: 99%
“…In another study of 62 patients with amyotrophic lateral sclerosis, the Cr/CysC ratio was shown to be associated with the severity of muscle loss (Tetsuka, ). Recently, a study in 285 patients with type 2 diabetes also indicated that the Cr/CysC ratio was consistent with the skeletal muscle mass estimated by bioelectrical impedance and could be used as a practical screening marker for sarcopenia (Osaka et al, ). In our study, we did not use the above methods except the Cr/CysC ratio to evaluate the muscle mass, due to the clinical instability of the patients at NCU admission.…”
Section: Discussionmentioning
confidence: 99%
“…We used the multifrequency impedance body composition analyzer, InBody 720 (InBody Japan, Tokyo, Japan), for evaluation of body composition . The result of this analyzer has a good correlation with the dual‐energy X‐ray absorptiometry method .…”
Section: Methodsmentioning
confidence: 99%
“…CysC is used as a serum marker to estimate GFR irrespective of the presence of chronic kidney disease and nutritional status [8]. Therefore, several studies have hypothesized that Scr or the Scr/CysC ratio could serve as a biomarker of SMM [12,13]. In addition, Lien et al [14] proposed another sarcopenia index (SI), the Scr 9 CysC-based GFR (GFR CysC ), which may be better correlated with SMM.…”
Section: Introductionmentioning
confidence: 99%